Biotech Values

[DewDiligence]

> POTP – I take this to mean that the results of this interim analysis will be made available to the company. If not, what's the point of it all?<

Normally, only the DSMB’s decision to continue or halt the study based on an interim look is made available to the sponsor of a blinded trial—the actual data from an interim look are normally not made available to the sponsor because doing so could compromise the integrity of subsequent data from the trial.

Perhaps, POTP’s trial is an exception to the above, but such exceptions are rare, in my experience.

Returning to the point in my previous post: if the only information that POTP will glean from the interim look is that the trial has not been halted for futility, I wouldn’t expect that to enable new financing on terms the company would consider attractive. Regards, Dew